Incorporates Best-In-Class Cyber-Security Protocols and Mobile App Controlled Omnipod BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 7, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod
Highlights Include Beyond Type Run Team NYC Marathon Sponsorship, NASDAQ Closing Bell Ceremony and Global Fundraising Events BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 5, 2018-- Insulet Corporation (NASDAQ:PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ®
Achieved Both Positive Operating and Net Income for the First Time in Insulet's History BILLERICA, Mass. --(BUSINESS WIRE)--Nov. 1, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System
Omnipod System to be Highlighted at the 54 th Annual Meeting of the European Association for the Study of Diabetes in Berlin, Germany LONDON --(BUSINESS WIRE)--Oct. 2, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with
BILLERICA, Mass. --(BUSINESS WIRE)--Sep. 24, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the third quarter of 2018
Timothy Scannell Will Become Chairman of the Board BILLERICA, Mass. --(BUSINESS WIRE)--Sep. 10, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced
BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 28, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet ), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at two upcoming investor conferences in New York City
BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 16, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it will showcase its recently FDA cleared Omnipod
Full Year 2018 Expected Revenue Growth Revised to 18% to 21% Third Quarter Expected Revenue Growth of 19% to 24% BILLERICA, Mass. --(BUSINESS WIRE)--Aug. 2, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ®
LONDON --(BUSINESS WIRE)--Jul. 12, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced that it has partnered with Glooko ® , Inc.
BILLERICA, Mass. --(BUSINESS WIRE)--Jul. 11, 2018-- Insulet Corporation (NASDAQ: PODD) ( Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced plans to release its financial results for the second quarter of 2018
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--Jul. 9, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced it has entered into a partnership with
Tubeless, Waterproof * Insulin Pump and Wireless, Handheld Personal Diabetes Manager Make Switching from Multiple Daily Injections to Pump Therapy Much Easier BILLERICA, Mass. & ONTARIO, Canada --(BUSINESS WIRE)--Jul. 3, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the
BILLERICA, Mass. & LONDON --(BUSINESS WIRE)--Jul. 2, 2018-- Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System (Omnipod System), today announced as of July 1 , it has assumed direct commercial
Omnipod ® Horizon ™ System Significantly Improves Glycemic Control in Patients with Type 1 Diabetes BILLERICA, Mass. --(BUSINESS WIRE)--Jun. 24, 2018-- Insulet Corporation (NASDAQ:PODD) (Insulet or the Company), the leader in tubeless insulin pump technology with its Omnipod ® Insulin Management
